Adalimumab - PDFSEARCH.IO - Document Search Engine

Adalimumab
Results: 358

#	Item
281	Wilcox Pharmacy/Option Care Respiratory Syncytial Virus (RSV) Prophylaxis Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2013-12-16 09:42:14 Immunosuppressants Monoclonal antibodies Autoimmune diseases Adalimumab Medical equipment Medical prescription Rheumatoid arthritis Psoriasis Syringe Medicine Pharmacology Health
282	Wilcox Pharmacy/Option Care Respiratory Syncytial Virus (RSV) Prophylaxis Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2014-06-03 15:08:15 Monoclonal antibodies Clinical pharmacology Medical prescription Patient safety Ustekinumab Adalimumab Syringe Etanercept Pharmacology Immunosuppressants Medicine
283	Wilcox Pharmacy/Option Care Respiratory Syncytial Virus (RSV) Prophylaxis Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2014-04-29 16:14:19 Health Immunosuppressants Monoclonal antibodies Centocor Adalimumab Syringe Medical prescription Etanercept Autoinjector Medicine Pharmacology Medical equipment
284	Anti-TNF Description Anti- tumor necrosis factor drugs are a class of drugs that have been used for more than 10 years. They are used worldwide to treat inflammatory conditions such as rheumatoid arthritis, psoriatic art Add to Reading List Source URL: www.rheumatology.org Language: English Pharmacology Autoimmune diseases Monoclonal antibodies Arthritis Rheumatology Etanercept Infliximab Adalimumab TNF inhibitor Medicine Health Immunosuppressants
285	InsideThis Issue DSQ Wound Healing and AntiRheumatic Agents.........................1 Add to Reading List Source URL: www.rheumatology.org Language: English Health Rheumatoid arthritis Leflunomide TNF inhibitor Disease-modifying antirheumatic drug Adalimumab Infliximab Etanercept Methotrexate Medicine Pharmacology Immunosuppressants
286	InsideThis Issue DSQ TNF inhibitors and Heart Failure...1 Add to Reading List Source URL: www.rheumatology.org Language: English Health Monoclonal antibodies Etanercept TNF inhibitor Adalimumab Infliximab Rheumatoid arthritis Cachexia Disease-modifying antirheumatic drug Medicine Pharmacology Immunosuppressants
287	DSQ InsideThis Issue FDA Update.............................1 Drug Safety Quarterly Add to Reading List Source URL: www.rheumatology.org Language: English Immunology Monoclonal antibodies Autoimmune diseases Arthritis TNF inhibitor Infliximab Etanercept Adalimumab Rheumatoid arthritis Medicine Pharmacology Immunosuppressants
288	DSQ Drug Safety Quarterly Vo l[removed]Wi n te r[removed] Add to Reading List Source URL: www.rheumatology.org Language: English Immunology Etanercept TNF inhibitor Adalimumab Anakinra Biologic Rheumatoid arthritis Leflunomide Rituximab Pharmacology Immunosuppressants Medicine
289	DSQ Drug Safety Quarterly Vo l[removed]No v e m b e r[removed] Add to Reading List Source URL: www.rheumatology.org Language: English Health Rheumatoid arthritis TNF inhibitor Adalimumab Anakinra Etanercept Infliximab Leflunomide Rituximab Medicine Immunosuppressants Pharmacology
290	DSQ Drug Safety Quarterly Vo l[removed]Sp ri n g[removed] Add to Reading List Source URL: www.rheumatology.org Language: English Pharmacology Rituximab Rheumatoid arthritis Leflunomide Adalimumab Anakinra Methotrexate Tocilizumab Disease-modifying antirheumatic drug Immunosuppressants Medicine Immunology

UPDATE